FDA Adds 37 Chinese Food Packaging Firms to Import Alert

On May 13, 2026, the U.S. Food and Drug Administration (FDA) updated Import Alert 99-08, adding 37 Chinese manufacturers of food-contact packaging—including plastic trays, aluminum foil laminates, and compostable food containers—to its automatic detention list. The action follows failure to submit complete compliance statements or test reports as required under 21 CFR Parts 174–179. This development directly affects U.S.-based importers, food brand owners, and global supply chain stakeholders relying on Chinese packaging suppliers—especially those active in ready-to-eat meals, fresh produce, and retail-ready packaging segments.

Event Overview

On May 13, 2026, the FDA issued an update to Import Alert 99-08, 'Detention Without Physical Examination of Food Contact Substances,' listing 37 newly added Chinese companies producing food-contact packaging materials. The stated reason is non-compliance with documentation requirements under 21 CFR Parts 174–179, specifically the absence of full compliance statements or supporting analytical test reports. Goods from these firms are now subject to automatic detention upon arrival at U.S. ports.

Industries Affected by Segment

Direct U.S. Importers of Food Products

U.S. importers who source finished food products packaged in materials supplied by any of the 37 listed Chinese manufacturers face immediate shipment delays or rejections. Since FDA’s automatic detention applies to the entire consignment—not just packaging—the presence of non-compliant packaging may halt entry of associated food items, triggering potential shelf-life loss, storage fees, and contractual penalties.

Food Brand Owners Using Contract Packaging

Brands outsourcing packaging procurement or co-packing to third-party facilities that rely on unregistered or non-declared Chinese suppliers are at indirect risk. If their contract packer uses packaging from a listed firm—and no valid FDA-compliant statement is on file—the final product may be detained, even if the brand itself holds no direct relationship with the supplier.

Chinese Packaging Manufacturers & Export Agents

Manufacturers not yet listed but operating in the same product categories (e.g., thermoformed plastic trays, multilayer barrier films, molded fiber containers) face heightened scrutiny. FDA’s selection criteria suggest emphasis on firms lacking active FDA registration, incomplete Form FDA 3480 submissions, or missing substance-specific migration testing aligned with 21 CFR Part 176–179.

Global Supply Chain Service Providers

Logistics providers, customs brokers, and regulatory consultants handling FDA-bound shipments must now verify packaging supplier compliance status before clearance submission. Failure to flag high-risk packaging sources may expose clients to unplanned detention events—and erode trust in end-to-end compliance assurance capabilities.

Key Focus Areas and Immediate Actions for Stakeholders

Verify Current Supplier FDA Registration and Documentation Status

U.S. importers and food brand owners should cross-check all active Chinese packaging suppliers against the latest Import Alert 99-08 list and confirm each has both: (i) a valid FDA facility registration (including DUNS number), and (ii) a signed, substance-specific compliance statement referencing applicable sections of 21 CFR Parts 174–179—with supporting test reports where required.

Review Packaging Specifications Against 21 CFR Part 174–179 Requirements

For each packaging component (e.g., adhesive layer in laminated foil, pigment in molded fiber), identify the precise regulatory subpart it falls under (e.g., 176.170 for components of paper and paperboard; 177.1520 for olefin polymers). Confirm whether the supplier’s declaration references the correct subpart and includes required limitations (e.g., extraction limits, temperature use conditions).

Assess Impact on Upcoming Shipments and Activate Contingency Protocols

If a listed supplier appears in current purchase orders or open bills of lading, contact U.S. customs brokers immediately to determine whether entry filings have been submitted. For pending shipments, consider requesting voluntary re-export or substitution prior to arrival—rather than waiting for formal detention notice. Document all communications and retain evidence of due diligence efforts.

Monitor FDA’s Public Database for Future Updates

FDA updates Import Alert 99-08 regularly, often without advance notice. Stakeholders should subscribe to FDA’s Import Alert email notifications and periodically search the FDA Warning Letters and Import Alerts database using keywords such as 'food contact,' 'plastic tray,' and 'aluminum laminate' to detect early signals of expanded enforcement.

Editorial Perspective / Industry Observation

Observably, this update reflects a tightening of FDA’s enforcement posture toward upstream packaging compliance—not a one-off audit outcome. The inclusion of 37 firms in a single update suggests systematic review of registration data and public submission gaps, rather than incident-driven action. Analysis shows the FDA is increasingly treating packaging as an integral part of food safety risk assessment, especially for ready-to-eat and ambient-stable products. From an industry perspective, this is less a sudden policy shift and more a signal that documentation rigor—particularly traceability from finished packaging back to individual substance declarations—is now a baseline expectation, not a compliance differentiator. Continued monitoring is warranted, as similar updates may follow for other Asian manufacturing hubs with comparable regulatory filing patterns.

In summary, the May 13, 2026 FDA action underscores that packaging compliance is no longer a secondary verification step—it is a prerequisite for market access. For affected stakeholders, the immediate priority is documentation validation and supply chain transparency; longer-term, it reinforces the need for integrated regulatory intelligence across sourcing, quality, and logistics functions. This event is best understood not as an isolated regulatory penalty, but as a calibration point in FDA’s broader emphasis on preventive controls across the full food contact materials supply chain.

Source: U.S. Food and Drug Administration (FDA) Import Alert 99-08, updated May 13, 2026. Note: Ongoing observation is recommended for subsequent FDA updates to this alert, as well as related guidance documents referencing 21 CFR Parts 174–179 implementation expectations.